$TSHA Taysha Gene Therapies, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Taysha Gene Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Taysha Gene Therapies, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Taysha Gene Therapies, Inc. for free.
IRS Number: 843199512
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: TSHA
Company Address: 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS 75247
Phone number: 212.551.8702
Taysha Gene Therapies, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | TSHA | Taysha Gene Therap ... | Nagendran Sukumar | Director | Option Exercise | A | 25.04 | 15,500 | 388,120 | 15,500 | |
| Jun 21 2021 | TSHA | Taysha Gene Therap ... | Reape Kathleen | Director | Option Exercise | A | 25.04 | 15,500 | 388,120 | 15,500 | |
| Jun 21 2021 | TSHA | Taysha Gene Therap ... | Sepp-Lorenzino Laura | Director | Option Exercise | A | 25.04 | 15,500 | 388,120 | 15,500 | |
| May 17 2021 | TSHA | Taysha Gene Therap ... | Manning Paul B | Director | Buy | P | 20.98 | 12,000 | 251,760 | 12,000 | 0 to 12 K |
| Jan 20 2021 | TSHA | Taysha Gene Therap ... | Session R.A. II | President and CEO | Option Exercise | A | 31.00 | 199,700 | 6,190,700 | 199,700 | |
| Jan 20 2021 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | A | 31.00 | 80,000 | 2,480,000 | 80,000 | |
| Jan 20 2021 | TSHA | Taysha Gene Therap ... | Alam Kamran | Chief Financial Off ... | Option Exercise | A | 31.00 | 70,000 | 2,170,000 | 70,000 | |
| Nov 24 2020 | TSHA | Taysha Gene Therap ... | Sepp-Lorenzino Laura | Director | Option Exercise | A | 21.77 | 31,000 | 674,870 | 31,000 | |
| Nov 24 2020 | TSHA | Taysha Gene Therap ... | Sepp-Lorenzino Laura | Director | Option Exercise | A | 21.77 | 31,000 | 674,870 | 31,000 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | C | 0.00 | 3,529 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Buy | C | 0.00 | 3,844 | 0 | 672,589 | 668.7 K to 672.6 K (+0.57 %) |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | C | 0.00 | 3,529 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Buy | C | 0.00 | 3,844 | 0 | 672,589 | 668.7 K to 672.6 K (+0.57 %) |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | C | 0.00 | 1,470 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | Nolan Sean P. | Director | Option Exercise | C | 0.00 | 1,000,000 | 0 | 0 |